These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 4137321
21. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators. Ealey PA, Valente WA, Ekins RP, Kohn LD, Marshall NJ. Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871 [Abstract] [Full Text] [Related]
22. Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs. Mukhtar ED, Smith BR, Pyle GA, Hall R, Vice P. Lancet; 1975 Mar 29; 1(7909):713-5. PubMed ID: 47482 [Abstract] [Full Text] [Related]
23. Isoelectric focusing of thyroid-stimulating antibody of Graves' disease. Zakarija M, McKenzie JM. Endocrinology; 1978 Oct 29; 103(4):1469-75. PubMed ID: 33803 [No Abstract] [Full Text] [Related]
24. On the effect of thyrotropin and immunoglobulins related to Graves' disease on thyrotropin synthesis and secretion. Dandona P, El Kabir DJ. Clin Endocrinol (Oxf); 1978 Oct 29; 9(4):321-7. PubMed ID: 581481 [No Abstract] [Full Text] [Related]
25. Validation of cytochemical section bioassay for thyroid-stimulating immunoglobulins in treated and untreated Graves' disease. Prentice MG, Alaghband-Zadeh J, Wise PH. J Immunoassay; 1984 Oct 29; 5(3-4):275-90. PubMed ID: 6549396 [Abstract] [Full Text] [Related]
26. Interaction between thyroid-stimulating immunoglobulins and thyrotropin receptors in fat cell membranes. Kishihara M, Nakao Y, Baba Y, Matsukura S, Kuma K, Fujita T. J Clin Endocrinol Metab; 1979 Nov 29; 49(5):706-11. PubMed ID: 226558 [Abstract] [Full Text] [Related]
28. Relationship between exophthalmogenic and thyroid-stimulating immunoglobulins in Graves' endocrine ophthalmopathy. Leövey A, Kálmán K, Szabó T, Lente K, Sándor P, Balázs C. Acta Med Acad Sci Hung; 1980 Nov 29; 37(4):345-50. PubMed ID: 6263033 [Abstract] [Full Text] [Related]
36. Heterogeneity of long acting thyroid stimulating (LATS)-activity, thyroglobulin antibodies and thyroid microsomal antibodies. Adlkofer F, Schleusener H, Uher L, Ananos A. Acta Endocrinol (Copenh); 1973 Jul 19; 73(3):483-8. PubMed ID: 4740843 [No Abstract] [Full Text] [Related]
37. Proceedings: Studies on long-acting thyroid stimulator protector in serum containing long-acting thyroid stimulator. Dirmikis S, Munro DS. J Endocrinol; 1975 Mar 19; 64(3):29P-30P. PubMed ID: 1173370 [No Abstract] [Full Text] [Related]
38. [Abnormality and deficiency in cellular immunity and internal diseases--Basedow's disease and cellular immunity]. Shishiba Y. Nihon Rinsho; 1978 Mar 19; 36(5):960-6. PubMed ID: 353330 [No Abstract] [Full Text] [Related]
39. A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease. McKenzie JM, Zakarija M. J Clin Endocrinol Metab; 1976 Apr 19; 42(4):778-81. PubMed ID: 177449 [Abstract] [Full Text] [Related]